GJWM
BIO icon

Gilliland Jeter Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gilliland Jeter Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9
Closed -$3.01K – 223
2024
Q3 		$3.01K Hold
9
– – ﹤0.01% 581
2024
Q2 		$2.46K Hold
9
– – ﹤0.01% 589
2024
Q1 		$3.11K Buy
+9
New +$2.96K ﹤0.01% 536

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Gilliland Jeter Wealth Management's BIO Position: Q4 2024 in Review

Gilliland Jeter Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2024, closing a stake of 9 shares — an estimated $3.01K sold.

Gilliland Jeter Wealth Management first reported a position in BIO in Q1 2024 and held it in 3 quarters. The position peaked at $3.11K in Q1 2024. 456 funds tracked by Wall St. Rank hold BIO as of Q4 2024.

  • Gilliland Jeter Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2024 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 9 Bio-Rad Laboratories Class A shares in Q4 2024, an estimated $3.01K.
  • Gilliland Jeter Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and held it in 3 quarters.
  • Gilliland Jeter Wealth Management's Bio-Rad Laboratories Class A position peaked at $3.11K in Q1 2024.
  • 456 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2024.

Based on Gilliland Jeter Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.